CONTACT

CONSENTS before CONTENT?

Lately, we have spent much time with clients talking and thinking about e-mail consent collection. It seems to be what every pharma marketeer is talking about these days.

The problem is that a lot of companies are doing it the wrong way around…

“FIRST, let’s obtain a lot of consents from our customers.
THEN, let’s make some good content to send to our customers.”

Sorry guys, that is just not the way to do it!

Building a consent database is always hard. But building one when you don’t have any content to show is extremely hard – and very expensive.
And try to put yourself in your customers’ place. When was the last time you signed up for something without seeing an example first?

Here is our take on email-marketing and consent collection:

1. Start by making some top-notch content and start sending it out? Even if you have very few customers to send it to.

2. Then use every opportunity to show customers your content. Face-to-face or online.

3. Ask if the customers would like to receive more like that.

4. Produce more quality content

5. Keep showing your good content

Obviously, it feels like a waste of time to create content for near-zero recipients, but the good thing is that you can reuse most content later when your audience has grown.

There are no shortcuts!

Have a great weekend. 😎